Role of 4-1BB in allograft rejection mediated by CD8+ T cells

American Journal of Transplantation

Volumn 3, Issue 5, 2003, Pages 543-551

  Wang, Jun ^a   Guo, Zhong ^a   Dong, Ying ^a   Kim, Oliver ^b   Hart, John ^b   Adams, Andrew ^a   Larsen, Christian P ^a   Mittler, Robert S ^a   Newell, Kenneth A ^a  

^a EMORY UNIVERSITY   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

Chemokines; Intestine; T lymphocytes; TNF receptor superfamily; Transplantation

Indexed keywords

ALLOANTIGEN; CD137 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CHEMOKINE; TUMOR NECROSIS FACTOR ALPHA;

ALLOGRAFT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; GENE EXPRESSION; GRAFT REJECTION; INTESTINE; MOUSE; NONHUMAN; POSTOPERATIVE COMPLICATION; SPLEEN; T LYMPHOCYTE;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD137; ANTIGENS, CD28; CD4-POSITIVE T-LYMPHOCYTES; CD40 LIGAND; CD8-POSITIVE T-LYMPHOCYTES; CELL DIVISION; FLOW CYTOMETRY; GRAFT REJECTION; INTESTINES; MICE; MICE, INBRED C57BL; RECEPTORS, NERVE GROWTH FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR; RECOMBINANT FUSION PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SPLEEN; TIME FACTORS; TRANSPLANTATION;

EID: 0037737886     PISSN: 16006135     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-6143.2003.00088.x     Document Type: Article

References (38)

1. Granger GA, Shacks SJ, Williams TW, Kolb WP. Lymphocyte in vitro cytotoxicityspecific release of lymphotoxin-like materials from tuberculin-sensitive lymphoid cells. Nature 1969; 221: 1155-1157.
2. Carswell EA, Old LJ, Kassel RL, Green S, Fiore N, Williamson B. An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci USA 1975; 72: 3666-3670.
3. Gravestein LA, Borst J. Tumor necrosis factor receptor family members in the immune system. Semin Immunol 1998; 10: 423-434.
4. Watts TH, DeBenedette MA. T cell co-stimulatory molecules other than CD28. Curr Opin Immunol 1999; 11: 286-293.
5. Locksley RM, Killeen N, Lenardo MJ. The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 2001; 104: 487-501.
6. Adams AB, Larsen CP, Pearson TC, Newell KA. The role of TNF receptor superfamily molecules in organ transplantation. Am J Transplant 2002; 2: 12-18.
7. Guo Z, Wang J, Meng L et al. Cutting edge: membrane lymphotoxin regulates cdB (+) t cell-mediated intestinal allograft rejection. J Immunol 2001; 167: 4796-4800.
8. Kwon BS, Weissman SM. cDNA sequences of two inducible T-cell genes. Proc Natl Acad Sci U S A 1989; 86: 1963-1967.
9. Pollok KE, Kim YJ, Zhou Z et al. Inducible T cell antigen 4-1BB. Analysis of expression and function. J Immunol 1993; 150: 771-781.
10. Vinay DS, Kwon BS. Role of 4-1BB in immune responses. Semin Immunol 1998; 10: 481-489.
11. Wilcox RA, Chapoval AI, Gorski KS et al. Cutting edge: expression of functional CD137 receptor by dendritic cells. J Immunol 2002; 168: 4262-4267.
12. Pollok KE, Kim YJ, Hurtado J, Zhou Z, Kim KK, Kwon BS. 4-1BB T-cell antigen binds to mature B cells and macrophages, and costimulates anti-mu-primed splenic B cells. Eur J Immunol 1994; 24: 367-374.
13. DeBenedette MA, Shahinian A, Mak TW, Watts TH. Costimulation of CD28- T lymphocytes by 4-1BB ligand. J Immunol 1997; 158: 551-559.
14. Goodwin RG, Din WS, Davis-Smith T et al. Molecular cloning of a ligand for the inducible T cell gene 4-1BB. a member of an emerging family of cytokines with homology to tumor necrosis factor. Eur J Immunol 1993; 23: 2631-2641.
15. Alderson MR, Smith CA, Tough TW et al. Molecular and biological characterization of human 4-1BB and its ligand. Eur J Immunol 1994; 24: 2219-2227.
16. DeBenedette MA, Chu NR, Pollok KE et al. Role of 4-1BB ligand in costimulation of T lymphocyte growth and its upregulation on M12 B lymphomas by cAMP. J Exp Med 1995; 181: 985-992.
17. Hurtado JC, Kim SH, Pollok KE, Lee ZH, Kwon BS. Potential role of 4-1BB in T cell activation. Comparison with the costimulatory molecule CD28. J Immunol 1995; 155: 3360-3367.
18. Hurtado JC, Kim YJ, Kwon BS. Signals through 4-1BB are costimulatory to previously activated splenic T cells and inhibit activation-induced cell death. J Immunol 1997; 158: 2600-2609.
19. Saoulli K, Lee SY, Cannons JL et al. CD28-independent, TRAF2-dependent costimulation of resting T cells by 4-1BB ligand. J Exp Med 1998; 187: 1849-1862.
20. Takahashi C, Mittler RS, Vella AT. Cutting edge: 4-1BB is a bona fide CD8 T cell survival signal. J Immunol 1999; 162: 5037-5040.
21. Melero I, Shuford WW, Newby SA et al. Monoclonal antibodies against the 4-1BB T-cell activation molecule eradicate established tumors. Nat Med 1997; 3: 682-685.
22. Melero I, Bach N, Hellstrom KE, Aruffo A, Mittler RS, Chen L. Amplification of tumor immunity by gene transfer of the co-stimulatory 4-1BB ligand synergy with the CD28 co-stimulatory pathway. Eur J Immunol 1998; 28: 1116-1121.
23. Mogi S, Sakurai J, Kohsaka T et al. Tumour rejection by gene transfer of 4-1BB ligand into a CD80 (+) murine squamous cell carcinoma and the requirements of co-stimulatory molecules on tumour and host cells. Immunology 2000; 101: 541-647.
24. Shuford WW, Klussman K, Tritchler DD et al. 4-1BB costimulatory signals preferentially induce CD8+ T cell proliferation and lead to the amplification in vivo of cytotoxic T cell responses. J Exp Med 1997; 186: 47-55.
25. Tan JT, Whitmire JK, Ahmed R, Pearson TC, Larsen CP. 4-1BB ligand, a member of the TNF family, is important for the generation of antiviral CD8 T cell responses. J Immunol 1999; 163: 4859-4868.
26. Tan JT, Whitmire JK, Murali-Krishna K et al. 4-1BB costimulation is required for protective anti-viral immunity after peptide vaccination. J Immunol 2000; 164: 2320-2325.
27. Blazar BR, Kwon BS, Panoskaltsis-Mortari A, Kwak KB, Peschon JJ, Taylor PA. Ligation of 4-1BB (CDw137) regulates graftversus-host disease, graft-versus-leukemia, and graft rejection in allogeneic bone marrow transplant recipients. J Immunol 2001; 166: 3174-3183.
28. He G, Hart J, Kim OS et al. The role of CD8 and CD4 T cells in intestinal allograft rejection: a comparison of monoclonal antibody-treated and knockout mice. Transplantation 1999; 67: 131-137.
29. Takahashi C, Mittler RS, Vella AT. Differential clonal expansion of CD4 and CD8 T cells in response to 4-1BB ligation contribution of 4-1BB during inflammatory responses. Immunol Lett 2001; 76: 183-191.
30. Mittler RS, Bailey TS, Klussman K, Trailsmith MD, Hoffmann MK. Anti-4-1BB monoclonal antibodies abrogate T cell-dependent humoral immune responses in vivo through the induction of helper T cell anergy. J Exp Med 1999; 190: 1535-1540.
31. Nozawa K, Ohata J, Sakurai J et al. Preferential blockade of CD8 (+) T cell responses by administration of anti-CD137 ligand monoclonal antibody results in differential effect on development of murine acute and chronic graft-versus-host diseases. J Immunol 2001; 167: 4981-4986.
32. Lakkis FG, Arakelov A, Konieczny BT, Inoue Y. Immunologic 'ignorance' of vascularized organ transplants in the absence of secondary lymphoid tissue. Nat Med 2000; 6: 686-688.
33. Larsen CP, Morris PJ, Austyn JM. Migration of dendritic leukocytes from cardiac allografts into host spleens. A novel pathway for initiation of rejection. J Exp Med 1990; 171: 307-314.
34. Cyster JG. Chemokines and cell migration in secondary lymphoid organs. Science 1999; 286: 2098-2102.
35. Ngo VN, Korner H, Gunn MD et al. Lymphotoxin alpha/beta and tumor necrosis factor are required for stromal cell expression of homing chemokines in B and T cell areas of the spleen. J Exp Med 1999; 189: 403-412.
36. Tan JT, Ha J, Cho HR et al. Analysis of expression and function of the costimulatory molecule 4-1BB in alloimmune responses. Transplantation 2000; 70: 175-183.
37. DeBenedette MA, Wen T, Bachmann MF et al. Analysis of 4-1BB ligand (4-1BBL) -deficient mice and of mice lacking both 4-1BBL and CD28 reveals a role for 4-1BBL in skin allograft rejection and in the cytotoxic T cell response to influenza virus. J Immunol 1999; 163: 4833-4841.
38. Krieger NR, Yin DP, Garrison Fathman C. CD4+ but not CD8+ cells are essential for allorejection. J Exp Med 1996; 184: 2013-2018.